Gevo, Inc. (NASDAQ:GEVO – Get Free Report) insider Kimberly Bowron sold 15,470 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $1.43, for a total transaction of $22,122.10. Following the completion of the sale, the insider directly owned 696,295 shares of the company’s stock, valued at $995,701.85. The trade was a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Gevo Stock Up 2.1%
Shares of GEVO stock traded up $0.03 during trading hours on Monday, hitting $1.43. 3,021,834 shares of the company were exchanged, compared to its average volume of 3,593,225. The company has a debt-to-equity ratio of 0.37, a quick ratio of 3.51 and a current ratio of 4.31. Gevo, Inc. has a one year low of $1.12 and a one year high of $2.97. The business’s 50-day simple moving average is $1.82 and its two-hundred day simple moving average is $2.00. The stock has a market capitalization of $348.08 million, a price-to-earnings ratio of -11.00 and a beta of 0.99.
Gevo (NASDAQ:GEVO – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The energy company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). Gevo had a negative return on equity of 5.06% and a negative net margin of 19.38%.The firm had revenue of $42.95 million during the quarter, compared to analyst estimates of $44.90 million. Sell-side analysts predict that Gevo, Inc. will post -0.11 EPS for the current fiscal year.
Institutional Investors Weigh In On Gevo
Analyst Upgrades and Downgrades
GEVO has been the subject of a number of research analyst reports. Northland Securities set a $3.50 price target on Gevo and gave the company an “outperform” rating in a report on Thursday, April 16th. Wall Street Zen downgraded shares of Gevo from a “hold” rating to a “strong sell” rating in a report on Sunday, May 10th. UBS Group reiterated a “neutral” rating and set a $2.00 target price (down from $2.25) on shares of Gevo in a research note on Friday, May 22nd. HC Wainwright reissued a “buy” rating on shares of Gevo in a report on Tuesday, May 26th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Gevo in a research report on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $2.75.
Read Our Latest Stock Analysis on Gevo
About Gevo
Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company’s core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo’s integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.
Gevo’s primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.
Recommended Stories
- Five stocks we like better than Gevo
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.
